Humacyte Stock Forecast - Rate Of Daily Change
| HUMA Stock | USD 3.80 0.54 12.44% |
Humacyte Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Humacyte stock prices and determine the direction of Humacyte's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Humacyte's historical fundamentals, such as revenue growth or operating cash flow patterns.
Humacyte |
| Previous Rate Of Daily Change | Rate Of Daily Change | Trend |
| 0.87 | 0.88 |
| Check Humacyte Volatility | Backtest Humacyte | Information Ratio |
Humacyte Trading Date Momentum
| On December 17 2024 Humacyte was traded for 3.79 at the closing time. The top price for the day was 3.79 and the lowest listed price was 3.79 . There was no trading activity during the period 0.0. Lack of trading volume on December 17, 2024 did not cause price change. The trading delta at closing time against the current closing price is 14.36% . |
The rate of daily change can indicate whether a given asset was oversold or over brought during a given period.
| Compare Humacyte to competition |
Other Forecasting Options for Humacyte
For every potential investor in Humacyte, whether a beginner or expert, Humacyte's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Humacyte Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Humacyte. Basic forecasting techniques help filter out the noise by identifying Humacyte's price trends.Humacyte Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Humacyte stock to make a market-neutral strategy. Peer analysis of Humacyte could also be used in its relative valuation, which is a method of valuing Humacyte by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Humacyte Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Humacyte's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Humacyte's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Humacyte Market Strength Events
Market strength indicators help investors to evaluate how Humacyte stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Humacyte shares will generate the highest return on investment. By undertsting and applying Humacyte stock market strength indicators, traders can identify Humacyte entry and exit signals to maximize returns.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.88 | |||
| Day Median Price | 3.8 | |||
| Day Typical Price | 3.8 | |||
| Price Action Indicator | (0.27) | |||
| Period Momentum Indicator | (0.54) |
Humacyte Risk Indicators
The analysis of Humacyte's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Humacyte's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting humacyte stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.73 | |||
| Standard Deviation | 5.17 | |||
| Variance | 26.76 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Humacyte is a strong investment it is important to analyze Humacyte's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Humacyte's future performance. For an informed investment choice regarding Humacyte Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Humacyte to cross-verify your projections. For information on how to trade Humacyte Stock refer to our How to Trade Humacyte Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Humacyte. If investors know Humacyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Humacyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.34) | Quarterly Revenue Growth (1.00) | Return On Assets (0.53) | Return On Equity (8.51) |
The market value of Humacyte is measured differently than its book value, which is the value of Humacyte that is recorded on the company's balance sheet. Investors also form their own opinion of Humacyte's value that differs from its market value or its book value, called intrinsic value, which is Humacyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Humacyte's market value can be influenced by many factors that don't directly affect Humacyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Humacyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Humacyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Humacyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.